公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2022 | Noninvasive assessment of liver function reserve with fluorescent dosimetry of indocyanine green | Wu, Pei Chun; Guo, Lun Zhang; Yu, Shan; Zeng, Ning; Liu, Yu Cheng; Yu, Jia; Zhang, Zhiming; Lu, Ke; Sun, Liangyu; Wang, Chunfei; Chang, Yu Han; Lu, Yin Lin; Shen, Yu Fang; Tai, Sheng; YUEH-HSUN CHUANG ; Annie Ho, Ja An; KAI-WEN HUANG ; YAO-MING WU ; Liu, Tzu Ming | Biomedical Optics Express | 2 | 1 | |
2015 | Novel Integration of an Ultrasound Probe and a Rotational-Scanning SQUID Biosusceptometer for Diagnosing Liver Tumors | Chieh J.J.; Lee Y.Y.; Wei W.C.; Hsiao P.Y.; KAI-WEN HUANG | IEEE Transactions on Applied Superconductivity | 0 | 0 | |
2018 | A novel photodynamic therapy-based drug delivery system layered on a stent for treating cholangiocarcinoma | PO-CHIN LIANG ; KAI-WEN HUANG ; CHIEN-CHIH TUNG ; MING-CHU CHANG ; Chang F.-Y.; Wong J.-M.; YU-TING CHANG | Biomedical Microdevices | 3 | 3 | |
2014 | Novel RNA oligonucleotide improves liver function and inhibits liver carcinogenesis in vivo | Reebye V.; S?trom P.; Mintz P.J.; KAI-WEN HUANG ; Swiderski P.; Peng L.; Liu C.; Liu X.; Lindk?r-Jensen S.; Zacharoulis D.; Kostomitsopoulos N.; Kasahara N.; Nicholls J.P.; Jiao L.R.; Pai M.; Spalding D.R.; Mizandari M.; Chikovani T.; Emara M.M.; Haoudi A.; Tomalia D.A.; Rossi J.J.; Habib N.A. | Hepatology | 94 | 91 | |
2013 | Optimization of the detection coil of high-Tc superconducting quantum interference device-based nuclear magnetic resonance for discriminating a minimum amount of liver tumor of rats in microtesla fields | Chen H.-H.; KAI-WEN HUANG ; Yang H.-C.; Horng H.-E.; Liao S.-H. | Journal of Applied Physics | 4 | 2 | |
2014 | The pilot experience upon surgical ablation of large liver tumor by microwave system with tissue permittivity feedback control mechanism | PO-CHIN LIANG ; HONG-SHIEE LAI ; TIFFANY TING-FANG SHIH ; CHIH-HORNG WU ; KAI-WEN HUANG | BMC Surgery | 9 | 7 | |
2013 | A pilot study of hepatic arterial infusion of chemotherapy for patients with advanced hepatocellular carcinoma who have failed anti-angiogenic therapy | YU-YUN SHAO ; PO-CHIN LIANG ; YAO-MING WU ; Huang C.-C.; KAI-WEN HUANG ; CHIA-HSIEN CHENG ; CHIH-HUNG HSU ; CHIUN HSU ; ANN-LII CHENG ; ZHONG-ZHE LIN | Liver International | 15 | 15 | |
2023 | Plasma Cell-Free Adenomatous Polyposis Coli Gene Promoter Methylation as a Prognostic Biomarker for Hepatocellular Carcinoma | Hsiao, Chih-Yang; Lu, Chang-Yi; Su, Hung-Ju; KAI-WEN HUANG | Research Square | | 0 | |
2019 | Positive Immuno-Modulation Following Radiofrequency Assisted Liver Resection in Hepatocellular Carcinoma | KAI-WEN HUANG ; Jayant, Kumar; PO-HUANG LEE ; Yang, Po-Chih; CHIH-YANG HSIAO ; Habib, Nagy; Sodergren, Mikael H | Journal of clinical medicine | 25 | 20 | |
2020 | Prognostic factor analysis of irreversible electroporation for locally advanced pancreatic cancer – A multi-institutional clinical study in Asia | Yang P.-C.; KAI-WEN HUANG ; Pua U.; Kim M.-D.; Li S.-P.; Li X.-Y.; PO-CHIN LIANG | European Journal of Surgical Oncology | 12 | 10 | |
2019 | A Prospective Assessment of the Diagnostic Value of Contrast-Enhanced Ultrasound, Dynamic Computed Tomography and Magnetic Resonance Imaging for Patients with Small Liver Tumors | CHIH-YANG HSIAO ; PO-DA CHEN ; KAI-WEN HUANG | Journal of clinical medicine | 18 | 15 | |
2019 | A prospective, multi-institution assessment of irreversible electroporation for treatment of locally advanced pancreatic adenocarcinoma: initial outcomes from the AHPBA pancreatic registry | Holland M.M.; Bhutiani N.; Kruse E.J.; Weiss M.J.; Christein J.D.; White R.R.; KAI-WEN HUANG ; Martin R.C.G.; II | HPB | 46 | 41 | |
2016 | Rapid and quantitative discrimination of tumour cells on tissue slices | KAI-WEN HUANG ; Chieh J.-J.; Liao S.-H.; Wei W.-C.; Hsiao P.-Y.; Yang H.-C.; Horng H.-E. | Nanotechnology | 2 | 1 | |
2020 | Recent advances: The imbalance of immune cells and cytokines in the pathogenesis of hepatocellular carcinoma | Jayant K.; Habib N.; KAI-WEN HUANG ; Warwick J.; Arasaradnam R. | Diagnostics | 16 | 14 | |
2015 | Signal analysis and liver tumor discrimination by using a high-Tc SQUID-based low-field NMR system in hospital | Liao S.-H.; Chieh J.-J.; Chou Y.-T.; Wang M.-W.; Chen H.-H.; KAI-WEN HUANG ; Yang H.-C.; Horng H.-E. | IEEE Transactions on Applied Superconductivity | 0 | 0 | |
2017 | Src-homology protein tyrosine phosphatase-1 agonist, SC-43, reduces liver fibrosis | TUNG-HUNG SU ; Shiau C.-W; Jao P; Yang N.-J; Tai W.-T; CHUN-JEN LIU ; TAI-CHUNG TSENG ; HUNG-CHIH YANG ; CHEN-HUA LIU ; KAI-WEN HUANG ; Hu T.-C; Huang Y.-J; YAO-MING WU ; Chen L.-J; PEI-JER CHEN ; DING-SHINN CHEN ; Chen K.-F; JIA-HORNG KAO | Scientific Reports | 12 | 11 | |
2015 | Sub-tesla-field magnetization of vibrated magnetic nanoreagents for screening tumor markers | Chieh J.-J.; KAI-WEN HUANG ; Shi J.-C. | Applied Physics Letters | 12 | 11 | |
2023 | Supplementary Figure 1 from MTL-CEBPA, a Small Activating RNA Therapeutic Upregulating C/EBP-α, in Patients with Advanced Liver Cancer: A First-in-Human, Multicenter, Open-Label, Phase I Trial | Debashis Sarker; Ruth Plummer; Tim Meyer; Mikael H. Sodergren; Bristi Basu; Cheng Ean Chee; KAI-WEN HUANG | American Association for Cancer Research | | | |
2023 | Supplementary Figure 2 from MTL-CEBPA, a Small Activating RNA Therapeutic Upregulating C/EBP-α, in Patients with Advanced Liver Cancer: A First-in-Human, Multicenter, Open-Label, Phase I Trial | Debashis Sarker; Ruth Plummer; Tim Meyer; Mikael H. Sodergren; Bristi Basu; Cheng Ean Chee; KAI-WEN HUANG ; et al., | American Association for Cancer Research | | | |
2023 | Supplementary Figure 3 from MTL-CEBPA, a Small Activating RNA Therapeutic Upregulating C/EBP-α, in Patients with Advanced Liver Cancer: A First-in-Human, Multicenter, Open-Label, Phase I Trial | Debashis Sarker; Ruth Plummer; Tim Meyer; Mikael H. Sodergren; Bristi Basu; Cheng Ean Chee; KAI-WEN HUANG ; et al., | American Association for Cancer Research | | | |